-+ 0.00%
-+ 0.00%
-+ 0.00%

CORCEPT PRESENTS COMPLETE DATA FROM PIVOTAL ROSELLA TRIAL IN SGO LATE-BREAKER WITH SIMULTANEOUS PUBLICATION IN THE LANCET: LIFYORLI™ (RELACORILANT) PLUS NAB-PACLITAXEL IMPROVES OVERALL SURVIVAL IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER

Reuters·04/10/2026 20:45:00

Please log in to view news